<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A recurrent <z:hpo ids='HP_0002617'>aneurysm</z:hpo> at the anastomosis site or the remaining artery frequently occurs after the operative treatment of an <z:hpo ids='HP_0002617'>aneurysm</z:hpo> in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease despite anti-inflammatory medication </plain></SENT>
<SENT sid="1" pm="."><plain>Herein, a ruptured left renal artery stump <z:hpo ids='HP_0002617'>aneurysm</z:hpo> in a patient with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, who received a left nephrectomy, aorto-biiliac bypass and heterotopic autotransplantation of the right kidney for the treatment of an <z:hpo ids='HP_0004953'>abdominal aortic aneurysm</z:hpo> and renal <z:hpo ids='HP_0000822'>hypertension</z:hpo> one year prior to this admission, is reported </plain></SENT>
<SENT sid="2" pm="."><plain>An <z:hpo ids='HP_0002617'>aneurysm</z:hpo> and rupture occurred despite the administration of anti-inflammatory medications while monitoring of the clinical findings, such as skin manifestations, erythrocyte segmentation rate (ESR) and C-reactive protein (CRP) </plain></SENT>
<SENT sid="3" pm="."><plain>Although there is no definite proven treatment modality to prevent recurrent <z:hpo ids='HP_0002617'>aneurysms</z:hpo> at the anastomosis site or a remote artery, close follow-up with anti-inflammatory medications, and surveillance with regular intervals are the only current methods for the prevention and/or to treatment of an arterial complication in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
</text></document>